BNC Korea Co., Ltd. (256840.KQ)

KRW 3880.0

(0.52%)

Total Assets Summary of BNC Korea Co., Ltd.

  • BNC Korea Co., Ltd.'s latest annual total assets in 2023 was 236.15 Billion KRW , up 1.56% from previous year.
  • BNC Korea Co., Ltd.'s latest quarterly total assets in 2024 Q2 was 244.92 Billion KRW , up 2.76% from previous quarter.
  • BNC Korea Co., Ltd. reported annual total assets of 232.52 Billion KRW in 2022, up 60.91% from previous year.
  • BNC Korea Co., Ltd. reported annual total assets of 144.5 Billion KRW in 2021, up 113.69% from previous year.
  • BNC Korea Co., Ltd. reported quarterly total assets of 238.36 Billion KRW for 2024 Q1, up 0.94% from previous quarter.
  • BNC Korea Co., Ltd. reported quarterly total assets of 227.65 Billion KRW for 2023 Q1, down -2.09% from previous quarter.

Annual Total Assets Chart of BNC Korea Co., Ltd. (2023 - 2016)

Historical Annual Total Assets of BNC Korea Co., Ltd. (2023 - 2016)

Year Total Assets Total Assets Growth
2023 236.15 Billion KRW 1.56%
2022 232.52 Billion KRW 60.91%
2021 144.5 Billion KRW 113.69%
2020 67.62 Billion KRW 36.34%
2019 49.59 Billion KRW 60.81%
2018 30.84 Billion KRW 107.0%
2017 14.9 Billion KRW -0.46%
2016 14.96 Billion KRW 0.0%

Peer Total Assets Comparison of BNC Korea Co., Ltd.

Name Total Assets Total Assets Difference
HLB Pharmaceutical Co., Ltd 141.35 Billion KRW -67.067%
CMG Pharmaceutical Co., Ltd. 186.85 Billion KRW -26.385%
Celltrion Pharm, Inc. 641.64 Billion KRW 63.196%
Huons Global Co., Ltd. 1317.96 Billion KRW 82.082%
DongKook Pharmaceutical Co., Ltd. 839.53 Billion KRW 71.871%
Enzychem Lifesciences Corporation 211.54 Billion KRW -11.632%
Humedix Co., Ltd. 219.97 Billion KRW -7.353%
Boditech Med Inc. 227.9 Billion KRW -3.62%
EuBiologics Co., Ltd. 172.64 Billion KRW -36.787%
FutureChem Co.,Ltd 72.83 Billion KRW -224.237%
Huons Co., Ltd. 537.28 Billion KRW 56.047%
AptaBio Therapeutics Inc. 92.51 Billion KRW -155.247%